{"1-120 Truncated Alpha-Synuclein Drosophila":{"PMID":"17376994","CurationStatus":"uncurated","Pages":"3338-3346","PublicationDate":["March 21"],"JournalVolume":"27","PublicationName":"The Journal of Neuroscience","Id":"nlx_organ_090801","JournalNumber":"12","Authors":["Magali Periquet","Tudor Fulga","Liisa Myllykangas","Michael G. Schlossmacher"],"Title":"Aggregated Alpha-Synuclein Mediates Dopaminergic Neurotoxicity In Vivo","Figure":"1-3","Definition":"This transgenic drosophila expresses a form of alpha-synuclein that is a C-terminally truncated fragment comprising amino acids 1-120.  This form of alpha-synuclein has an enhanced ability to aggregate and thus enhanced neurotoxicity.  This mutant is used in research to determine the role of alpha-synuclein aggregation in neurodegenerative diseases, such as Parkinsons."}}